GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgical Science Sweden AB (OSTO:SUS) » Definitions » ROC (Joel Greenblatt) %

Surgical Science Sweden AB (OSTO:SUS) ROC (Joel Greenblatt) % : 163.47% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Surgical Science Sweden AB ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Surgical Science Sweden AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 163.47%.

The historical rank and industry rank for Surgical Science Sweden AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:SUS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -71.32   Med: 201.82   Max: 337.96
Current: 221.28

During the past 9 years, Surgical Science Sweden AB's highest ROC (Joel Greenblatt) % was 337.96%. The lowest was -71.32%. And the median was 201.82%.

OSTO:SUS's ROC (Joel Greenblatt) % is ranked better than
94.89% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 10.07 vs OSTO:SUS: 221.28

Surgical Science Sweden AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Surgical Science Sweden AB ROC (Joel Greenblatt) % Historical Data

The historical data trend for Surgical Science Sweden AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Science Sweden AB ROC (Joel Greenblatt) % Chart

Surgical Science Sweden AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only 201.82 213.50 212.14 337.96 274.93

Surgical Science Sweden AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 455.43 559.46 88.18 130.99 163.47

Competitive Comparison of Surgical Science Sweden AB's ROC (Joel Greenblatt) %

For the Health Information Services subindustry, Surgical Science Sweden AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Science Sweden AB's ROC (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's ROC (Joel Greenblatt) % falls into.



Surgical Science Sweden AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(96.25 + 177.767 + 0) - (0 + 0 + 256.325)
=17.692

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(130.839 + 174.235 + 0.00099999999997635) - (0 + 0 + 243.825)
=61.25

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Surgical Science Sweden AB for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=183.14/( ( (75.427 + max(17.692, 0)) + (69.699 + max(61.25, 0)) )/ 2 )
=183.14/( ( 93.119 + 130.949 )/ 2 )
=183.14/112.034
=163.47 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgical Science Sweden AB  (OSTO:SUS) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Surgical Science Sweden AB ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Surgical Science Sweden AB's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Science Sweden AB Business Description

Traded in Other Exchanges
Address
Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.

Surgical Science Sweden AB Headlines

No Headlines